EUVIMEDEUVIMED entdecken
Fallbericht

Pulmonary Artery Denervation for Refractory Sjögren's Syndrome‐Associated Pulmonary Arterial Hypertension: A Case Report of Combined Hemodynamic and Renal Recovery

Jingjing Hu, Fengyou Yao iD

Catheterization and Cardiovascular Interventions · 2026-05 · 107 (6) · 1847-1850

DOI: 10.1002/ccd.70546 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 09.03.2026. Verfasst von Jingjing Hu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Fifth People's Hospital of Chengdu, Chengdu, China. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Pulmonary Artery, Arterial Pressure, Pulmonary Arterial Hypertension. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 31‐year‐old woman with primary Sjögren's syndrome presented with severe pre‐capillary pulmonary arterial hypertension (mean pulmonary arterial pressure 51 mmHg, pulmonary vascular resistance 14.7 Wood units) and active renal impairment (24‐hour urinary protein 1290 mg). Despite initial immunosuppressive therapy and dual oral PAH‐targeted treatment with ambrisentan and tadalafil, she remained at high risk. She subsequently underwent pulmonary artery denervation (PADN) using a 45‐mm ablation catheter with 120‐second radiofrequency applications at three sites on the main pulmonary artery. At 2‐month follow‐up, she demonstrated significant symptomatic improvement to WHO functional class I, with a 6‐minute walk distance of 320 meters, improved hemodynamics (mean pulmonary arterial pressure 35 mmHg, pulmonary vascular resistance 5.63 Wood units), and a reduced NT‐proBNP level of 320 pg/mL, achieving an intermediate‐low risk status according to the 2022 ESC/ERS guidelines. Renal function also improved (24‐hour urinary protein 158 mg). This case suggests that PADN may be an effective adjunctive interventional strategy for refractory autoimmune PAH, even with concurrent renal involvement, facilitating simultaneous cardiopulmonary and renal recovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromePulmonary ArteryArterial PressurePulmonary Arterial HypertensionKidneyCatheter AblationHumansFemaleTreatment OutcomeAdultRecovery of FunctionAntihypertensive AgentsImmunosuppressive Agents

Stichwörter der Autor:innen

Sjögren's syndromecase reportpulmonary arterial hypertensionpulmonary artery denervationrenal impairment

Substanzen

Antihypertensive AgentsImmunosuppressive Agents

Autor:innen und Institutionen

  • Fifth People's Hospital of Chengdu, Chengdu, China.

ORCID-Profile: Fengyou Yao

Zitieren

APA

Hu, J., & Yao, F. (2026). Pulmonary Artery Denervation for Refractory Sjögren's Syndrome‐Associated Pulmonary Arterial Hypertension: A Case Report of Combined Hemodynamic and Renal Recovery. Catheterization and Cardiovascular Interventions, 107(6), 1847-1850. https://doi.org/10.1002/ccd.70546

Vancouver

Hu J, Yao F. Pulmonary Artery Denervation for Refractory Sjögren's Syndrome‐Associated Pulmonary Arterial Hypertension: A Case Report of Combined Hemodynamic and Renal Recovery. Catheterization and Cardiovascular Interventions. 2026;107(6):1847-1850. doi:10.1002/ccd.70546

BibTeX
@article{Hu2026,
  author = {Hu, Jingjing and Yao, Fengyou},
  title = {Pulmonary Artery Denervation for Refractory Sjögren's Syndrome‐Associated Pulmonary Arterial Hypertension: A Case Report of Combined Hemodynamic and Renal Recovery},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  volume = {107},
  number = {6},
  pages = {1847--1850},
  doi = {10.1002/ccd.70546}
}
Kostenlos starten →